Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05258292

Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes

Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes: the GLYMETY Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
86 (estimated)
Sponsor
Institut de Recherches Cliniques de Montreal · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

In clinical practice, women living with type 1 diabetes frequently report that insulin requirements change across the menstrual cycle. Consequently, glycemic fluctuations are observed. This phenomenon could be explained by a decrease in insulin sensitivity during the second half of the menstrual cycle (luteal phase). Overall, despite an important proportion of women reporting glycemic and/or insulin variations across the menstrual cycle, studies to date have involved small sample sizes, and have had inconsistent results. The objective of this study will be to study glycemic fluctuations across the menstrual cycle using CGM data, alongside insulin data, in a large sample of women.

Conditions

Interventions

TypeNameDescription
DEVICEContinuous glucose monitoringGlucose levels will be measured using continuous glucose monitoring
DRUGInsulinInsulin doses will be retrieved from insulin pump reports (for insulin pump users) or journals for (for multiple daily injections users)
OTHERPremenstrual symptomsPremenstrual symptoms will be assessed using the Premenstrual symptoms screening tool
OTHEROvulation kitsOvulation testing will be done using ovulation kits
DEVICEFitbit Inspire 2Physical activity will be assessed using the Fitbit Inspire 2
OTHERKeenoaFood intake will be assessed using the Keenoa phone application
OTHERMenstrual cycleThe application My Calendar will be used to record information on the menstrual cycle

Timeline

Start date
2022-05-02
Primary completion
2026-04-01
Completion
2026-05-31
First posted
2022-02-28
Last updated
2026-03-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05258292. Inclusion in this directory is not an endorsement.